These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Association of serum macrophage-mannose receptor CD206 with mortality in idiopathic pulmonary fibrosis. Zou R, Gui X, Zhang J, Tian Y, Liu X, Tian M, Chen T, Wu H, Chen J, Dai J, Cai H. Int Immunopharmacol; 2020 Sep; 86():106732. PubMed ID: 32622200 [Abstract] [Full Text] [Related]
8. Macrophage-specific nanotechnology-driven CD163 overexpression in human macrophages results in an M2 phenotype under inflammatory conditions. Alvarado-Vazquez PA, Bernal L, Paige CA, Grosick RL, Moracho Vilrriales C, Ferreira DW, Ulecia-Morón C, Romero-Sandoval EA. Immunobiology; 2017 Aug; 222(8-9):900-912. PubMed ID: 28545809 [Abstract] [Full Text] [Related]
9. Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages. Soldano S, Pizzorni C, Paolino S, Trombetta AC, Montagna P, Brizzolara R, Ruaro B, Sulli A, Cutolo M. PLoS One; 2016 Aug; 11(11):e0166433. PubMed ID: 27846260 [Abstract] [Full Text] [Related]
10. Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study. Andersen ES, Rødgaard-Hansen S, Moessner B, Christensen PB, Møller HJ, Weis N. Eur J Clin Microbiol Infect Dis; 2014 Jan; 33(1):117-22. PubMed ID: 24424890 [Abstract] [Full Text] [Related]
16. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease. Enomoto Y, Suzuki Y, Hozumi H, Mori K, Kono M, Karayama M, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suzuki D, Ogawa N, Nakashima R, Mimori T, Iwashita T, Suda T. Arthritis Res Ther; 2017 Jan 19; 19(1):9. PubMed ID: 28103926 [Abstract] [Full Text] [Related]